Reliability of salivary theophylline in monitoring the treatment for apnoea of prematurity

Journal of Perinatology

Volumn 27, Issue 11, 2007, Pages 709-712

  Chereches Panta, P ^a   Nanulescu, M V ^a   Culea, M ^b   Palibroda, N ^c  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b BABE BOLYAI UNIVERSITY   (Romania)

^c TECHNICAL UNIVERSITY OF CLUJ NAPOCA   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG MONITORING; DRUG SALIVA LEVEL; FEMALE; GESTATIONAL AGE; HUMAN; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MALE; NEWBORN; NEWBORN APNEA; RELIABILITY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

AMINOPHYLLINE; APNEA; BRONCHODILATOR AGENTS; DRUG MONITORING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MALE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SALIVA; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; THEOPHYLLINE;

EID: 35648965676     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211804     Document Type: Article

References (17)

1. Calhoun LK. Pharmacologic management of apnea of prematurity (Review). J Perinatal Neonatal Nurs 1996; 9(4): 56-62.
2. Herzlinger R. Apnea In: Oski FA (ed). Principles and Practice of Pediatrics. JB Lippincott company. Philadelphia, PA, 1994, pp 381-382.
3. Hogue SL, Phelps SJ. Evaluation of the three theophylline dosing equations for use in infants up to one year of age. J Pediatr 1993; 123: 651-656.
4. Bhatt-Mehta V, Johnson CE, Donn SM, Spadoni V, Schork MA. Accuracy and reliability of dosing equations to individualize theophylline treatment of apnea of prematurity. Pharmacolher 1995; 15(2): 246-250.
5. Kraus DM, Hatzoupoulos FK, Reitz SJ, Fischer JH. Pharmacokinetic evaluation of two theophylline dosing methods for infants. Ther Drug Monit 1994; 16(3): 270-276.
6. Koysooko R, Ellis EF, Levy G. Relationship between theophylline concentration in plasma and saliva in man. Clin Pharmacol 1974; 15: 454.
7. Khanna NN, Bada HS, Somani SM. Use of salivary concentrations in the prediction of serum caffeine and theophylline concentrations in premature infants. J Pediatr 1980, 96(3): 494-499.
8. Aviram M, Tal A, Ben-Zvi Z, Gorodisher R. Monitoring theophylline therapy using citric acid-stimulated saliva in infants and children with asthma. Pediatrics 1987; 80(6): 84-897.
9. Toback JW, Gal P, Erkan NV, Roop C, Robinson H. Usefulness of theophylline saliva levels in neonates. Ther Drug Monit 1983; 5 2): 185-189.
10. Milsap RL, Hill MR, Szefler SJ. Special pharmakokinetic considerations in children. In: Evans WE, Schentag JJ, Jusko WJ (eds). Applied Pharmacokinetics, Principles of Therapeutic Drug Monitoring, Third edition. Applied Therapeutics Inc.: Spokane, WA, 1992; 10-1-10-25.
11. Moore ES, Faix RG, Banagale RC, Grasela TH. The population pharmacokinetics of theophylline in neonates and young infants. J Pharm Biopharm 1989; 17(1): 46-66.
12. Nahata MC. Pediatrics. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM (eds). Pharmacotherapy, A Pathophysiology Approach Third edition. Appleton & Lange: Stamford, CT, 1997; 77-85.
13. Martin III ES. The population pharmakonetics of theophylline during the early postneonatal period. J Pharm Biopharm 1991; 19(3): 59S-77S.
14. Liu H, Delgado MR. Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants. Clin Pharmacokinet 1999; 36(6): 453-470.
15. Vasudev A, Tripathi ED, Puri V. Correlation of serum and salivary carbamazepine concentration in epileptic patients: Implications for therapeutic drug monitoring. Neurol India 002; 50: 69-62.
16. Gorodischer R, Burtin P, Verjee Z, Hwang P, Koren G. Is saliva suitable for therapeutic monitoring of anticonvulsants in children. An evaluation in the routine clinical setting. Ther Drug Monit 1997; 19 6): 637-642.
17. Khanna NN, Somani SM, Boyer A, Miller Y, Chua C, Meuke JA et al. Cross validation of serum to saliva relationship of caffeine, theophylline and total methylxantine in neonates. Dev Pharmacol Ther 1982; 4(1-2): 18-27.